BI 224436
Sponsors
Boehringer Ingelheim
Conditions
HIV InfectionsHealthy
Phase 1
Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers.
WithdrawnNCT01276990
Start: 2011-01-31Updated: 2012-02-09
Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.
CompletedNCT02183662
Start: 2009-11-30Updated: 2014-07-08